Cargando…
Combined agonists act synergistically to increase mucociliary clearance in a cystic fibrosis airway model
Mucus clearance, a primary innate defense mechanism of airways, is defective in patients with cystic fibrosis (CF) and CF animals. In previous work, the combination of a low dose of the cholinergic agonist, carbachol with forskolin or a β adrenergic agonist, isoproterenol synergistically increased m...
Autores principales: | Joo, Nam Soo, Cho, Hyung-Ju, Shinbashi, Meagan, Choi, Jae Young, Milla, Carlos E., Engelhardt, John F., Wine, Jeffrey J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458446/ https://www.ncbi.nlm.nih.gov/pubmed/34552115 http://dx.doi.org/10.1038/s41598-021-98122-5 |
Ejemplares similares
-
Marked increases in mucociliary clearance produced by synergistic secretory agonists or inhibition of the epithelial sodium channel
por: Joo, Nam Soo, et al.
Publicado: (2016) -
Effect of airway clearance therapies on mucociliary clearance in adults with cystic fibrosis: A randomized controlled trial
por: Trimble, Aaron, et al.
Publicado: (2022) -
Characterizing Mucociliary Clearance in Young Children with Cystic Fibrosis
por: Laube, Beth L., et al.
Publicado: (2022) -
Tromethamine improves mucociliary clearance in cystic fibrosis pigs
por: Ash, Jamison J., et al.
Publicado: (2022) -
Elastic mucus strands impair mucociliary clearance in cystic fibrosis pigs
por: Pino-Argumedo, Maria I., et al.
Publicado: (2022)